Artificial tissue is prepared in the laboratory but has the property of living tissue, so it is used as a substitute of natural tissue. The manufacture of artificial fabrics is done using many bio-fabrication techniques. The primary benefit associated with artificial tissue deployment is its ability to deliver growth factor near the wound site, where it is planted. Artificial tissues are currently considered a promising area of medical research and biotechnology. With the growing popularity of artificial tissues embedded in artificial organs, the demand for artificial tissues is expected to increase significantly over the forecast period, supported by the advanced application of AI in medical sciences. This impressive growth rate is also facilitated by the growing application of 3D printing in the healthcare industry. 3D bioprinting has made it possible to develop vascularized tissue, almost 10 times thicker and composed of living human cells.
Access the full description of this report at:-
The artificial tissue market includes various market players such as Tissue Regenix Group plc, Baxter International, Inc., Integra LifeSciences Corporation, Allergen Plc., Zimmer Biomet Holdings, Inc., Becton, Dickinson and Company, Wright Medical Group, Taxus Cardium Pharmaceuticals, American CryoStem and Asterias Biotherapeutics. Major market players are focusing on continuous product innovation, investing more in R&D activities. For example, Buffalo Research University has introduced the creation of three-dimensional artificial tissue, with an advancement goal that could improve experimental drug testing, the quality of artificial organs.
Additionally, in September 2020, Rice and the University of Washington (UW) announced their initial investment strategy to remotely control cellular functions of 3D artificial tissues. These remote technologies will further assist in controlling tissue positioning and timing.
Market dynamics and trends
A meteoric surge has been observed in the advancement of medical science with a mixture of growing awareness regarding organ transplantation. According to data released by the US government in September 2019, more than 120,000 patients are in the queue for organ transplantation and every 10 minutes a new patient is added to the list. This is expected to bolster the demand for artificial fabrics over the next decade.
Over the last half-decade, 3D bioprinting has made its way into organ and tissue transplantation and has proven to be crucial. This technology is widely used in the development of artificial fabrics. 3D bio-printing is gaining momentum due to its advantage of being less rejected by the human body. Additionally, the integration of artificial intelligence in the manufacturing of artificial fabrics is poised to boost the growth trend of the market.
However, the unprecedented Covid-19 event has brutally impacted several sectors in a multitude of ways, which has flattened the curve of the global economy. Due to the pandemic, the artificial tissue market witnessed a moderate decline due to increased involvement of medical institutions towards Covid patients and limited manufacturing capacity due to lockdown and social distancing measures. Additionally, the patient’s decision to postpone the transplant given the spread of the virus globally has limited the market growth.
Request a sample copy of this report from:-
North America is expected to dominate the global artificial fabrics market throughout the forecast period (2022-2030). Indeed, the United States has the highest demand for organ transplants in the world. In 2019, there were about 123 per million people who had transplants. However, Europe is expected to gain more traction than the global average. This is attributed to the higher transplant rate in Spain and France, which are 117 and 90 per million people respectively. In addition, increasing number of elderly people and increasing expenditure on skin and bone treatment would further pave the way for skin and bone tissue markets in the region.
On the other hand, Asia-Pacific is considered as an emerging market for artificial owing to the increase in investments from major players and growing demand from patients. China holds the maximum market share in the Asia-Pacific region. This is attributed to the increasing use of 3D bioprinting in healthcare.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a trusted, independent third-platform market intelligence provider committed to delivering high-quality market research reports that help multinational companies triumph over their competitors and grow their footprint in the industry by capturing a larger market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analysis.
We have served over 1,000 clients worldwide, including 90% of Fortune 500 companies for a decade. Our analysts constantly track various high-growth markets and identify hidden opportunities in each sector or industry. We provide one of the best quality syndicates in the industry along with custom research reports across 10 different verticals. We are committed to providing high quality research solutions in line with your business needs. Our industry standard delivery solution that ranges from pre-consultation to after-sales services, provides excellent customer experience and ensures good strategic decision making for businesses.
For more information, please visit, https://www.nextmsc.com